Lipid Kinetics

Clinical Diabetes Research: Methods and Techniques

Volumn , Issue , 2007, Pages 151-168

  Miles, John M ^a   Nelson, Robert H ^a  

^a MAYO CLINIC   (United States)

Author keywords

Chylomicron triglyceride concentration; Diagnostic cardiac catheterisation; Euglycemic and hyperinsulinemic clamp; Free fatty acids; Lipid fuel metabolism; Non lipolytic tissues; Plasma insulin concentration; Radiolabeled triglyceride

Indexed keywords

DIAGNOSIS;

DIAGNOSTIC CARDIAC CATHETERISATION; FREE FATTY ACID; LIPID FUELS; LIPOLYTIC; PLASMA INSULIN CONCENTRATION; RADIOLABELED TRIGLYCERIDE;

FATTY ACIDS;

EID: 84889496269     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470513095.ch9     Document Type: Chapter

References (95)

1. Armstrong DT, Steele R, Altszuler N, Dunn A, Bishop JS, DeBodo RC (1961) Regulation of plasma free fatty acid turnover Am J Physiol 201, 9-15.
2. Barrows BR, Timlin MT, Parks EJ (2005) Spillover of dietary fatty acids and use of serum nonesterified fatty acids for the synthesis of VLDL-triacylglycerol under two different feeding regimens Diabetes 54, 2668-2673.
3. Barter PJ, Nestel PJ (1972) Plasma free fatty acid transport during prolonged glucose consumption and its relationship to plasma triglyceride fatty acids in man J Lipid Res 13, 483-490.
4. Basso LV, Havel RJ (1970) Hepatic metabolism of free fatty acids in normal and diabetic dogs J Clin Invest 49, 537-547.
5. Beylot M, Martin C, Beaufrere B, Riou JP, Mornex R (1987) Determination of steady state and nonsteady-state glycerol kinetics in humans using deuterium-labeled glycerol J Lipid Res 28, 414-422.
6. Bjorntorp P, Bergman H, Varnauskas E, Lindholm B (1969) Lipid mobilization in relation to body composition in man Metabolism 18, 840-851.
7. Blaner WS, Obunike JC, Kurlandsky SB, al-Haideri M, Piantedosi R, Deckelbaum RJ, Goldberg IJ (1994) Lipoprotein lipase hydrolysis of retinyl ester Possible implications for retinoid uptake by cells J Biol Chem 269, 16, 559-16, 565.
8. Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM Diabetes 46, 3-10.
9. Boden G, Jadali F, White J, Liang Y, Mozzoli M, Chen X, Coleman E, Smith C (1991) Effects of fat on insulin stimulated carbohydrate metabolism in normal men J Clin Invest, 960-966.
10. Brunzell JD, Hazzard WR, Porte D, Jr, Bierman EL (1973) Evidence for a common, saturable, triglyceride removal mechanism for Chylomicrons and very low density lipoproteins in man J Clin Invest 52, 1578-1585.
11. Brunzell J, Porte DJ, Bierman E (1979) Abnormal lipoprotein-lipase-mediated plasma triglyceride removal in untreated diabetes mellitus associated with hypertriglyceridemia Metabolism 28, 901-907.
12. Cohen J (1989) Chylomicron triglyceride clearance, comparison of three assessment methods Am J Clin Nutr 49, 306-313.
13. Coppack SW, Persson M, Judd RL, Miles JM (1999) Glycerol and nonesterified fatty acid metabolism in human muscle and adipose tissue in vivo Am J Physiol 276, E233-E240.
14. Dagenais GR, Tancredi RG, Zierler KL (1976) Free fatty acid oxidation by forearm muscle at rest, and evidence for an intramuscular lipid pool in the human forearm J Clin Invest 58, 421-431.
15. Dietschy JM, Turley SD, Spady DK (1993) Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans J Lipid Res 34, 1637-1659.
16. Dole VP (1956) A relation between non-esterified fatty acids in plasma and the metabolism of glucose J Clin Invest 35, 150-154.
17. Duncombe WG, Rising TJ (1973) Quantitative extraction and determination of nonesterified fatty acids in plasma J Lipid Res 14, 258-261.
18. Eckel RH (1989) Lipoprotein lipase, a multifunctional enzyme relevant to common metabolic diseases N Engl J Med 320, 1060-1068.
19. Evans K, Burdge GC, Wootton SA, Clark ML, Frayn KN (2002) Regulation of dietary fatty acid entrapment in subcutaneous adipose tissue and skeletal muscle Diabetes 51, 2684-2690.
20. Finegood DT, Bergman RN, Vranic M (1987) Estimation of endogenous glucose production during hyperinsulinaemic euglycaemic glucose clamps, comparison of unlabelled and labelled exogenous glucose infusates Diabetes 36, 914-924.
21. 14- labelled unesterified fatty acids in normal human subjects J Clin Invest 37, 1504-1515.
22. 2H stable isotopic tracers Anal Biochem 205, 172-178.
23. Gold M, Spitzer JJ (1964) Metabolism of free fatty acids by myocardium and kidney Am J Physiol 206, 153-158.
24. Goodpaster BH, Wolfe RR, Kelley DE (2002) Effects of obesity on substrate utilization during exercise Obes Res 10, 575-584.
25. Gormsen LC, Jensen MD, Nielsen S (2006a) Measuring VLDL-triglyceride turnover in humans using ex vivo-prepared VLDL tracer J Lipid Res 47, 99-106.
26. Gormsen LC, Jensen MD, Schmitz O, Moller N, Christiansen JS, Nielsen S (2006b) Energy expenditure, insulin, and VLDL triglyceride production in humans J Lipid Res.
27. Guo Z, Nielsen S, Burguera B, Jensen MD (1997) Free fatty acid turnover measured using ultralow doses of [U-13C]palmitate J Lipid Res 38, 1888-1895.
28. Hagenfeldt L (1975) Turnover of individual free fatty acids in man Federation Proc 34, 2246-2249.
29. Hagenfeldt L, Wahren J (1968) Human forearm muscle metabolism during exercise II Uptake, release and oxidation of individual FFA and glycerol Scand J Clin Lab Invest 21, 263-276.
30. Harris P, Chlouverakis C, Gloster J, Jones JH (1962) Arterio-venous differences in the composition of plasma free fatty acids in various regions of the body Clin Sci 22, 113-118.
31. Havel RJ, Kane JP, Balasse EO, Segel N, Basso LV (1970) Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans JClinInvest 49, 2017-2035.
32. Hazzard WR, Bierman EL (1976) Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia) Metabolism 25, 777-801.
33. Hultin M, Carneheim C, Rosenqvist K, Olivecrona T (1995) Intravenous lipid emulsions, removal mechanisms as compared to chylomicrons J Lipid Res 36, 2174-2184.
34. Iriyama K, Nishiwaki H, Terashima H, Tonouchi H, Miki C, Suzuki H, Carpentier Y(1988) Apolipoprotein C-II modifications associated with an infusion of artificial lipid particles JPEN12, 60-62.
35. Isley WL, Miles JM, Patterson BW, Harris WS (2006) The effect of high-dose simvastatin on triglyceride-rich lipoprotein metabolism in patients with type 2 diabetes mellitus J Lipid Res 47, 193-200.
36. Jensen MD, Heiling VJ (1991) Heated hand vein blood is satisfactory for measurements during free fatty acid kinetic studies Metabolism 40, 406-409.
37. Jensen MD, Heiling VJ, Miles JM (1990) Measurement of non-steady-state free fatty acid turnover Am J Physiol 258, E103-E108.
38. Jensen MD, Rogers PJ, Ellman MG, Miles JM (1988) Choice of infusion-sampling mode for tracer studies of free fatty acid metabolism Am J Physiol 254, E562-E565.
39. Jensen MD, Sarr MG, Dumesic DA, Southorn PA, Levine JA (2003) Regional uptake of meal fatty acids in humans Am J Physiol Endocrinol Metab 285, E1282-1288.
40. Judd RL, Nelson R, Klein S, Jensen MD, Miles JM (1998) Measurement of plasma glycerol specific activity by high performance liquid chromatography to determine glycerol flux J Lipid Res 39, 1106-1110.
41. Karpe F, Humphreys S, Samra J, Summers L, Frayn K (1997) Clearance of lipoprotein remnant particles in adipose tissue and muscle in humans J Lipid Res 38, 2335-2343.
42. Klein S, Young VR, Blackburn GL, Bistrian BR, Wolfe RR (1986) Palmitate and glycerol kinetics during brief starvation in normal weight young adult and elderly subjects J Clin Invest 78, 928-933.
43. Lemieux S, Fontani R, Uffelman KD, Lewis GF, Steiner G (1998) Apolipoprotein B-48 and retinyl palmitate are not equivalent markers of postprandial intestinal lipoproteins J Lipid Res 39, 1964-1971.
44. Lewis G, Uffelman K, Szeto L, Weller B, Steiner G (1995) Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans J Clin Invest 95, 158-166.
45. Lichtenstein AH, Hachey DL, Millar JS, Jenner JL, Booth L, Ordovas J, Schaefer EJ (1992) Measurement of human apolipoprotein B-48 and B-100 kinetics in triglyceride-rich lipoproteins using [5, 5, 5-2H3]leucine J Lipid Res 33, 907-914.
46. Lin EC (1977) Glycerol utilization and its regulation in mammals Annu Rev Biochem 46, 765-795.
47. Lutz O, Meraihi Z, Mura J-L, Riess GH, Back AC (1989) Fat emulsion particle size, influence on the clearance rate and the tissue lipolytic activity Am J Clin Nutr 50, 1370-1381.
48. Martin ML, Jensen MD (1991) Effects of body fat distribution on regional lipolysis in obesity J Clin Invest 88, 609-613.
49. Martins IJ, Mortimer BC, Miller J, Redgrave TG (1996) Effects of particle size and number on the plasma clearance of chylomicrons and remnants J Lipid Res 37, 2696-2705.
50. McGarry JD (1992) What if Minkowski had been ageusic? An alternative angle on diabetes Science, 258, 766-770.
51. Miles JM, Glasscock R, Aikens J, Gerich JE, Haymond MW (1983) A microfluorometric method for the determination of free fatty acids in plasma J Lipid Res 24, 96-99.
52. Miles JM, Ellman MG, McClean KL, Jensen MD (1987) Validation of a new method for determination of free fatty acid turnover Am J Physiol 252, E431-E438.
53. Miles JM, Judd RL, Persson M, Coppack SW (1995) Methods for estimating the kinetics of lipid fuels in vivo In Research Methodologies in Human Diabetes Mogensen CE, Standl W, Eds New York, Walter de Gruyter, 345-359.
54. Miles JM, Park Y, Harris WS (2001) Lipoprotein lipase and triglyceride-rich lipoprotein metabolism Nutr Clin Pract 16, 273-279.
55. Miles J, Park Y, Walewicz D, Russell-Lopez C, Windsor S, Isley W, Coppack S, Harris W (2004) Systemic and forearm triglyceride metabolism, fate of lipoprotein lipase-generated glycerol and free fatty acids Diabetes 53, 521-527.
56. Miller HI, Gold M, Spitzer JJ (1962) Removal and mobilization of individual free fatty acids in dogs Am J Physiol 202, 370-374.
57. Mittendorfer B, Liem O, Patterson BW, Miles JM, Klein S (2003) What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean? Diabetes 52, 1641-1648.
58. Most AS, Brachfeld N, Gorlin R, Wahren J (1969) Free fatty acid metabolism of the human heart at rest J Clin Invest 48, 1177-1188.
59. Nakandakare E, Lottenberg S, Oliveira H, Bertolami M, Vasconcelos K, Sperotto G, Quintao E (1994) Simultaneous measurements of chylomicron lipolysis and remnant removal using a doubly labeled artificial lipid emulsion, studies in normolipidemic and hyperlipidemic subjects J Lipid Res 35, 143-152.
60. Nelson RH, Prasad A, Lerman A, Miles J (2007) Myocardial uptake of circulating triglycerides in nondiabetic patients with heart disease. Diabetes 56, 527.
61. Nelson RH, Edgerton DS, Basu R, Roesner JC, Cherrington AD, Miles JM (in press) Triglyceride uptake and lipoprotein lipase-generated fatty acid spillover in the splanchnic bed of dogs Diabetes.
62. Nestel P, Denborough M, O'Dea J (1962) Disposal of human chylomicrons administered intravenously in ischaemic heart disease and essential hyperlipemia Circ Res 10, 786-791.
63. Nielsen S, Guo Z, Albu JB, Klein S, O'Brien PC, Jensen MD (2003) Energy expenditure, sex, and endogenous fuel availability in humans J Clin Invest 111, 981-988.
64. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD (2004) Splanchnic lipolysis in human obesity J Clin Invest 113, 1582-1588.
65. Nikkila E, Kekki M (1973) Plasma triglyceride transport kinetics in diabetes mellitus Metabolism 22, 1-22.
66. Northrop DB (1981) The expression of isotope effects on enzyme-catalyzed reactions Annu Rev Biochem 50, 103-131.
67. Nurjhan N, Campbell PJ, Kennedy FP, Miles JM, Gerich JE (1986) Insulin dose-response characteristics for suppression of glycerol release and conversion to glucose in humans Diabetes 35, 1326-1331.
68. Park Y, Damron BD, Miles JM, Harris WS (2001) Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion Lipids 36, 115-120.
69. Park Y, Grellner WJ, Harris WS, Miles JM (2000) A new method for the study of chylomicron kinetics in vivo Am J Physiol 279, E1258-E1263.
70. Parks EJ, Krauss RM, Christiansen MP, Neese RA, Hellerstein MK (1999) Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance J Clin Invest 104, 1087-1096.
71. Patterson BW, Mittendorfer B, Elias N, Satyanarayana R, Klein S (2002) Use of stable isotopically labeled tracers to measure very low density lipoprotein-triglyceride turnover J Lipid Res 43, 223-233.
72. Quarfordt SH, Frank A, Shames DM, Berman M, Steinberg D (1970) Very low density lipoprotein triglyceride transport in type IV hyperlipoproteinemia and the effects of carbohydrate-rich diets J Clin Invest 49, 2281-2297.
73. Reaven G, Hill D, Gross R, Farquhar J (1965) Kinetics of triglyceride turnover of very-low-density lipoproteins of human plasma J Clin Invest 44, 1826-1833.
74. Redgrave TG (2004) Chylomicron metabolism Biochem Soc Trans 32, 79-82.
75. Redgrave T, Ly H, Quintao E, Ramberg C, Boston R (1993) Clearance from plasma of triacylglycerol and cholesteryl ester after intravenous injection of chylomicron-like lipid emulsions in rats and man Biochem J 290, 843-847.
76. Redgrave TG, Maranhao RC (1985) Metabolism of protein-free lipid emulsion models of chylomicrons in rats Biochim Biophys Acta 835, 104-112.
77. Romanski SA, Nelson RM, Jensen MD (2000) Meal fatty acid uptake in human adipose tissue, technical and experimental design issues Am J Physiol 279, E447-454.
78. Rossner S (1974) Studies on an intravenous fat tolerance test Methodological, experimental and clinical experiences with Intralipid Acta Med Scand 564, 1-24.
79. Roust LR, Jensen MD (1993) Postprandial free fatty acid kinetics are abnormal in upper body obesity Diabetes 42, 1567-1573.
80. Rumsey SC, Galeano NF, Arad Y, Deckelbaum RJ (1992) Cryopreservation with sucrose maintains normal physical and biological properties of human plasma low density lipoproteins J Lipid Res 33, 1551-1561.
81. Rumsey SC, Stucchi AF, Nicolosi RJ, Ginsberg HN, Ramakrishnan R, Deckelbaum RJ (1994) Human plasma LDL cryopreserved with sucrose maintains in vivo kinetics indistinguishable from freshly isolated human LDL in cynomolgus monkeys J Lipid Res 35, 1592-1598.
82. Seidner DL, Mascioli EA, Istfan NW, Porter KA, Selleck K, Blackburn GL, Bistrian BR (1989) Effects of long-chain triglyceride emulsions on reticuloendothelial system function in humans JPEN 13, 614-619.
83. Sidossis LS, Coggan AR, Gastaldelli A, Wolfe RR (1995) A new correction factor for use in tracer estimations of plasma fatty acid oxidation Am J Physiol 269, E649-656.
84. Sidossis LS, Magkos F, Mittendorfer B, Wolfe RR (2004) Stable isotope tracer dilution for quantifying very low-density lipoprotein-triacylglycerol kinetics in man Clin Nutr 23, 457-466.
85. Sigurdsson G, Nicoll A, Lewis B (1975) Conversion of very low density lipoprotein to low density lipoprotein A metabolic study of apolipoprotein B kinetics in human subjects J Clin Invest 56, 1481-1490.
86. Sparks JD, Sparks CE (1994) Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion Biochim Biophys Acta 1215, 9-32.
87. Spector AA (1975) Fatty acid binding to plasma albumin JLipid Res 16, 165-179.
88. Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron AD (1997) Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation J Clin Invest 100, 1230-1239.
89. Stojiljkovic MP, Zhang D, Lopes HF, Lee CG, Goodfriend TL, Egan BM (2001) Hemodynamic effects of lipids in humans Am J Physiol 280, R1674-R1679.
90. Vaughan M (1962) The production and release of glycerol by adipose tissue incubated in vitro J Biol Chem 237, 3354-3358.
91. Wahren J, Hagenfeldt L, Felig P (1975) Splanchnic and leg exchange of glucose, amino acids, and free fatty acids during exercise in diabetes mellitus J Clin Invest 55, 1303-1314.
92. Winkler B, Steele R, Altszuler N (1969) Effects of growth hormone administration on free fatty acid and glycerol turnover in the normal dog Endocrinology 85, 25-30.
93. 14C-labelled substrates in humans J Clin Invest 79, 359-366.
94. 13C]palmitic acid Biomed Mass Spectrom 7, 168-171.
95. Wolfe RR, Shaw JHF, Durkot MJ (1985) Effects of sepsis on VLDL kinetics, responses in basal state and during glucose infusion Am J Physiol 248, E732-E740.